Myoclonus and its disorders

被引：9

作者：

Blindauer, K ^{[1
]}

机构：

[1] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA

来源：

NEUROLOGIC CLINICS | 2001年 / 19卷 / 03期

关键词：

D O I：

10.1016/S0733-8619(05)70042-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

This article defines myoclonus, describes the numerous causes of myoclonus, and summarizes various classification schemes. The electrodiagnostic characteristics and pathophysiology of this movement disorder are described. Treatment of the various forms of myoclonus is also discussed.

引用

页码：723 / +

页数：13

共 70 条

[1] Myoclonus associated with the use of gabapentin [J].

Asconapé, J ;

Diedrich, A ;

DellaBadia, J .

EPILEPSIA, 2000, 41 (04) :479-481

[2] Abnormalities of the balance between inhibition and excitation in the, motor cortex of patients with cortical myoclonus [J].

Brown, P ;

Ridding, MC ;

Werhahn, KJ ;

Rothwell, JC ;

Marsden, CD .

BRAIN, 1996, 119 :309-317

[3] MYOCLONUS - A PRACTICAL GUIDE TO DRUG-THERAPY [J].

BROWN, P .

CNS DRUGS, 1995, 3 (01) :22-29

[4]

BROWN P, 1991, BRAIN, V114, P197

[5] Myoclonus [J].

Brown, P .

CURRENT OPINION IN NEUROLOGY, 1996, 9 (04) :314-316

[6]

BROWNE TR, 1983, EPILEPSY DIAGNOSIS M, P235

[7] The incidence and prevalence of myoclonus in Olmsted County, Minnesota [J].

Caviness, JN ;

Alving, LI ;

Maraganore, DM ;

Black, RA ;

McDonnell, SK ;

Rocca, WA .

MAYO CLINIC PROCEEDINGS, 1999, 74 (06) :565-569

[8]

Caviness JN, 1996, MAYO CLIN PROC, V71, P679

[9] CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE-OXIDASE INHIBITOR, AND CLONAZEPAM [J].

CHADWICK, D ;

HALLETT, M ;

HARRIS, R ;

JENNER, P ;

REYNOLDS, EH ;

MARSDEN, CD .

BRAIN, 1977, 100 (SEP) :455-487

[10]

De Lean J, 1986, Adv Neurol, V43, P215

← 1 2 3 4 5 6 7 →